TScan Therapeutics, Inc. TCRX · Insights

website

138

TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineere...

Price0.1816

Market Cap12.2 M

Float51.47 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Key Dates & Timelines

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro

Financial Transactions

Form Type

Date

Description

Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro